These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 31619064)

  • 41. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Killing the Culprit: Pharmacological Solutions to Get Rid of Cholesterol Crystals.
    Iranshahy M; Banach M; Hasanpour M; Lavie CJ; Sahebkar A
    Curr Probl Cardiol; 2022 Sep; 47(9):101274. PubMed ID: 35661813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility and Clinical Significance of In Vivo Cholesterol Crystal Detection Using Optical Coherence Tomography.
    Katayama Y; Tanaka A; Taruya A; Kashiwagi M; Nishiguchi T; Ozaki Y; Matsuo Y; Kitabata H; Kubo T; Shimada E; Kondo T; Akasaka T
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):220-229. PubMed ID: 31619064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis.
    Iannaccone M; Quadri G; Taha S; D'Ascenzo F; Montefusco A; Omede' P; Jang IK; Niccoli G; Souteyrand G; Yundai C; Toutouzas K; Benedetto S; Barbero U; Annone U; Lonni E; Imori Y; Biondi-Zoccai G; Templin C; Moretti C; Luscher TF; Gaita F
    Eur Heart J Cardiovasc Imaging; 2016 Oct; 17(10):1128-37. PubMed ID: 26508517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OCT for the identification of vulnerable plaque in acute coronary syndrome.
    Sinclair H; Bourantas C; Bagnall A; Mintz GS; Kunadian V
    JACC Cardiovasc Imaging; 2015 Feb; 8(2):198-209. PubMed ID: 25677892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.
    Nidorf SM; Fiolet A; Abela GS
    J Clin Lipidol; 2020; 14(5):619-630. PubMed ID: 32792218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation.
    Dekker M; Waissi F; Timmerman N; Silvis MJM; Timmers L; de Kleijn DPV
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.
    Baumer Y; McCurdy SG; Boisvert WA
    Adv Biol (Weinh); 2021 Nov; 5(11):e2100638. PubMed ID: 34590446
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.